share_log

Lei Liu Bought 516% More Shares In China Jo-Jo Drugstores

Lei Liu Bought 516% More Shares In China Jo-Jo Drugstores

劉磊購買了九洲大藥房更多的股份516%
Simply Wall St ·  09/07 21:42

China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) shareholders (or potential shareholders) will be happy to see that the Chairman & CEO, Lei Liu, recently bought a whopping US$4.7m worth of stock, at a price of US$1.87. That purchase boosted their holding by 516%, which makes us wonder if the move was inspired by quietly confident deeply-felt optimism.

九洲大藥房(NASDAQ:CJJD)的股東(或潛在股東)會高興地看到,董事長兼首席執行官劉磊最近以1,870萬美元的價格購買了令人矚目的470萬美元的股票。這次購買增加了他們的持股比例516%,這讓我們想知道這一舉動是否源於內心深處的樂觀情緒。

The Last 12 Months Of Insider Transactions At China Jo-Jo Drugstores

在最後十二個月中,九洲大藥房內部交易中的最新交易數據顯示:實際上,根據我們的記錄,劉磊最近的購買是該公司股票內部個人交易中最大的一筆交易。這意味着一個內部人士願意以高於當前價格1.51美元的價格購買股票。他們很可能對這次購買感到後悔,但更有可能他們對該公司持看好態度。在我們看來,內部人士購買股票的價格非常重要。一般規則是,當內部人士以高於當前價格購買股票時,我們對該股更爲積極樂觀,因爲這意味着他們認爲該股具有較高的價值,即使價格較高。劉磊是過去一年中唯一一位個人內部人士購買股票的人。

In fact, the recent purchase by Lei Liu was the biggest purchase of China Jo-Jo Drugstores shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at above the current price of US$1.51. It's very possible they regret the purchase, but it's more likely they are bullish about the company. In our view, the price an insider pays for shares is very important. As a general rule, we feel more positive about a stock when an insider has bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Lei Liu was the only individual insider to buy during the last year.

根據我們的記錄,劉磊最近的購買是九洲大藥房內部人士在過去十二個月中所作出的最大交易,這表明他們願意以高於1.51美元的當前價格購買股票。他們很可能對這次購買感到後悔,但更有可能他們對該公司持看好態度。在我們看來,內部人士購買股票的價格非常重要。一般規則是,當內部人士以高於當前價格購買股票時,我們對該股更爲積極樂觀,因爲這意味着他們認爲該股具有較高的價值,即使價格較高。劉磊是過去一年中唯一一位個人內部人士購買股票的人。

The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!

以下圖表顯示了過去一年中公司和個人的內部交易。單擊下面的圖表,即可查看每個內部交易的詳細信息!

big
NasdaqCM:CJJD Insider Trading Volume September 7th 2024
納斯達克CM:CJJD 內部交易成交量 2024年9月7日

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

還有很多其他的公司,公司的內部人士正在購買股票。你可能不想錯過這個免費的小市值公司的低估列表。

Insider Ownership

內部人員持股情況

Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. It's great to see that China Jo-Jo Drugstores insiders own 45% of the company, worth about US$4.5m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

許多投資者喜歡查看公司內部持股比例。我們通常喜歡看到較高水平的內部持股。看到九洲大藥房內部持股佔公司的45%,價值約450萬美元,感到很高興。我喜歡看到這種水平的內部持股,因爲它增加了管理層考慮股東最佳利益的機會。

So What Do The China Jo-Jo Drugstores Insider Transactions Indicate?

那麼九洲大藥房內部交易究竟暗示着什麼?

The recent insider purchase is heartening. And the longer term insider transactions also give us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about China Jo-Jo Drugstores. Looks promising! While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Case in point: We've spotted 4 warning signs for China Jo-Jo Drugstores you should be aware of, and 2 of them don't sit too well with us.

最近的內部購買令人振奮。而長期的內部交易也讓我們充滿信心。然而,我們注意到公司在過去十二個月內沒有盈利,這讓我們感到謹慎。除了高內部持股外,這一分析表明內部人士對九洲大藥房抱有較看好態度。看起來很有前途!雖然了解內部人士的持股和交易情況是很好的,但在做出任何投資決策之前,我們確保也考慮了一支股票面臨的風險。例子如下:我們發現了4個對九洲大藥房的警示信號,您應該注意其中有2個讓我們不太滿意。

Of course China Jo-Jo Drugstores may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

當然,九洲大藥房可能不是最佳的股票購買選擇。因此,您可能希望查看這些高質量公司的免費選股套件。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

對於本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論